ALLR STOCKHOLDER ALERT: Bronstein, Gewirtz and Grossman, LLC Announces that Allarity Therapeutics, Inc. Investors with Losses Have Opportunity to Lead Class Action Lawsuit!Accesswire • 10/02/24
The Schall Law Firm Invites Shareholder Participation In A Securities Fraud Case Against Allarity Therapeutics, Inc.Accesswire • 10/01/24
ALLR INVESTOR ALERT: Bronstein, Gewirtz and Grossman, LLC Reminds Stockholders of Allarity Therapeutics, Inc. to Contact the Firm Today!Accesswire • 10/01/24
ROSEN, TRUSTED INVESTOR COUNSEL, Encourages Allarity Therapeutics, Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action – ALLRGlobeNewsWire • 09/30/24
Allarity Therapeutics Inc Is Being Sued For Violating Securities Laws And Impacted Investors Are Invited To Assist The Schall Law FirmAccesswire • 09/29/24
Shareholder Rights Law Firm Robbins LLP Encourages Allarity Therapeutics, Inc. Stockholders with Large Losses to Contact the Firm for Information About the ALLR Securities Class ActionBusiness Wire • 09/28/24
The Schall Law Firm Encourages Stockholder Participation In A Securities Fraud Case Against Allarity Therapeutics, Inc.Accesswire • 09/27/24
ROSEN, LEADING TRIAL ATTORNEYS, Encourages Allarity Therapeutics, Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action – ALLRGlobeNewsWire • 09/27/24
SHAREHOLDER ACTION REMINDER ALERT: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of Allarity TherapeuticsAccesswire • 09/27/24
The Schall Law Firm Invites Shareholders To Take Part In A Securities Fraud Case Against Allarity Therapeutics, Inc.Accesswire • 09/25/24
ALLR INVESTOR ALERT: Edelson Lechtzin LLP Reminds Allarity Therapeutics, Inc. (NASDAQ: ALLR) Shareholders About the Lead Plaintiff Deadline in the Pending Securities Fraud Class ActionAccesswire • 09/25/24
Allarity Therapeutics, Inc Class Action Alert: Wolf Haldenstein Adler Freeman & Herz LLP reminds investors that a securities class action lawsuit has been filed in the United States District Court for the Southern District of New York against Allarity Therapeutics, Inc.PRNewsWire • 09/24/24
ALLR CLASS ACTION REMINDER - Robbins LLP Reminds Stockholders of the Lead Plaintiff Deadline in the Allarity Therapeutics, Inc. Securities Class ActionGlobeNewsWire • 09/24/24
ROSEN, GLOBAL INVESTOR COUNSEL, Encourages Allarity Therapeutics, Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action – ALLRGlobeNewsWire • 09/24/24
Allarity Therapeutics, Inc Class Action Alert: Wolf Haldenstein Adler Freeman & Herz LLP reminds investors that a securities class action lawsuit has been filed in the United States District Court for the Southern District of New York against Allarity Therapeutics, Inc.Accesswire • 09/23/24
ALLR INVESTOR ALERT: Edelson Lechtzin LLP Urges Allarity Therapeutics, Inc. (NASDAQ: ALLR) Shareholders to Consult Legal Counsel About the Pending Securities Fraud Class ActionGlobeNewsWire • 09/23/24
Allarity Therapeutics Inc Is Being Sued For Securities Related Infractions And Affected Investors Are Urged To Contact The Schall Law FirmAccesswire • 09/22/24
The Schall Law Firm Invites Stockholder Participation In A Securities Fraud Case Against Allarity Therapeutics, Inc.Accesswire • 09/21/24
Allarity Therapeutics Inc Is Being Sued For Violating Securities Regulations And The Schall Law Firm Urges Investors To Reach OutAccesswire • 09/20/24
ALLR Lawsuit Reminder - Robbins LLP Reminds Stockholders of the Allarity Therapeutics, Inc. Class Action LawsuitBusiness Wire • 09/20/24
ROSEN, A LEADING LAW FIRM, Encourages Allarity Therapeutics, Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action – ALLRGlobeNewsWire • 09/20/24
Deadline Reminder: Law Offices of Howard G. Smith Reminds Investors of Looming Deadline in the Class Action Lawsuit Against Allarity Therapeutics, Inc. (ALLR)Business Wire • 09/20/24
Stakeholders With Losses In Allarity Therapeutics, Inc. Are Invited To Contact The Schall Law Firm About A Securities Fraud LawsuitAccesswire • 09/20/24
Glancy Prongay & Murray LLP, a Leading Securities Fraud Law Firm, Announces the Filing of a Securities Class Action on Behalf of Allarity Therapeutics, Inc. (ALLR) InvestorsBusiness Wire • 09/19/24
Allarity Therapeutics Inc May Have Defrauded The Public And The Schall Law Firm Seeks Investor Participation In A CaseAccesswire • 09/18/24